 |
인쇄하기
취소
|
Boryung eying sales of 100 billion won with new drug
Boryung Pharmaceutical Co. said its 74 newly recruited salespersons have been under intensive product training for Kanarb (fimasartan), a new drug for hypertension.
The company filed an application with the country's health watchdog last March to market Kanar in a bid to raise 100 billion won in domestic sales within the next five years,
Kanarb is one of several drugs belongs to angioten...
The company filed an application with the country's health watchdog last March to market Kanar in a bid to raise 100 billion won in domestic sales within the next five years,
Kanarb is one of several drugs belongs to angioten...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.